The global ophthalmic combination product market size was estimated at USD 12,980 million in 2024 and is projected to surpass around USD 26,260 million by 2034, expanding at a CAGR of 7.3% from 2024 to 2034.
The ophthalmic combination products are an integral part of the healthcare industry. The products that combine drugs, devices, and/or biological products for treating eye conditions are termed as ophthalmic combination products. These products use technologies such as intraocular implants, drug-eluting contact lenses and micro/nanoparticles for delivering therapeutic agents to the eye. For example, eye droppers packaged with an ophthalmic drug.
The increasing adoption of medical devices for drug delivery as they offer a user-friendly and reliable option compared to the old methods which is expanding the market usage of combination products. The rising prevalence of eye disorders such as dry eye disease, glaucoma, cataracts and the acceptance of ophthalmic combination products by patients and healthcare providers with multiple advantages for safer and effective eye treatments is driving the market growth.
The innovative developments in ophthalmic combination products with improved delivery to the eye and increased patient compliance are the factors expected to create opportunities for the key market players in the upcoming years.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
| Stats ID: | 7198 |
| Format: | Databook |
| Published: | December 2024 |
| Price | US$ 1550 |
Immediate Delivery
| Stats ID: | 7198 |
| Format: | Databook |
| Published: | December 2024 |
| Price | US$ 1550 |
Immediate Delivery
Unlock unlimited access to all exclusive market research reports, empowering your business.
Get industry insights at the most affordable plan
Stay ahead of the competition with comprehensive, actionable intelligence at your fingertips!
Learn More
